Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P253: The impact of storage time and freeze–thaw cycles on faecal calprotectin concentration in inflammatory bowel disease patients and controls

ECCO '19 Copenhagen

Year: 2019
Authors:

C. Caenepeel*1, K. Machiels1, S. Vieira-Silva2, N. Ardeshir Davani1, M. Ferrante1,3, S. Vermeire1,3

1KU Leuven, TARGID, Leuven, Belgium, 2Rega Institute for Medical Research, Microbiology and Immunology, Leuven, Belgium, 3University hospitals Leuven, Gastroenterology and Hepatology, Leuven, Belgium

P254: Re-defining the concept of endoscopic and histological healing by using electronic virtual chromoendoscopy and probe confocal endomicroscopy in ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Iacucci*1,2,3,4, R. Cannatelli3, S. X. Gui5, B. C. Lethebe6, A. Bazarova3, G. Gkoutos3, G. Kaplan7, R. Panaccione7, R. Kiesslich8, S. Ghosh1,3,4

1University of Birmingham, Institute of Immunology and Immunotherapy, Birmingham, UK, 2University of Calgary, IBD Unit, Calgary, Canada, 3University of Birmingham, Institute of Translational Medicine, Birmingham, UK, 4National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, Birmingham, UK, 5University of Calgary, Department of Pathology, Calgary, Canada, 6University of Calgary, Research Unit, Calgary, Canada, 7University of Calgary, IBD Unit, Birmingham, UK, 8HSK Hospital, Division of Gastroenterology, Wiesbaden, Germany

P255: Perceived disease severity and treatment satisfaction among patients with ulcerative colitis in Europe

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Armuzzi*1, M. Tarallo2, D. Bargo3, J. Lucas4, D. Bluff4, B. Hoskin4, L. Salese5, J. Cappelleri6, C. Kayhan5, M. DiBonaventura8

1Fondazione Policlinico Gemelli IRCCS – Università Cattolica del Sacro Cuore, Rome, Italy, 2Pfizer Inc., Rome, Italy, 3Pfizer Inc., New York, USA, 4Adelphi Real World, Macclesfield, UK, 5Pfizer Inc., Collegeville, USA, 6Pfizer Inc., Groton, USA, 8Pfizer Inc., Patient and Health Impact, New York, USA

P256: Bowel contrast-enhanced ultrasound perfusion imaging in the evaluation of Crohn's disease patients

ECCO '19 Copenhagen

Year: 2019
Authors:

L. Laterza*1, M. E. Ainora1, M. Garcovich1, A. Poscia2, A. Lupascu3, L. Riccardi1, F. Scaldaferri1, A. Armuzzi4, A. Gasbarrini1, G. L. Rapaccini4, M. Pompili1, M. A. Zocco1

1Fondazione Policlinico A. Gemelli IRCCS, Internal Medicine and Gastroenterology, Rome, Italy, 2Catholic University, Institute of Public Health, Rome, Italy, 3Fondazione Policlinico A. Gemelli IRCCS, Angiology, Rome, Italy, 4Fondazione Policlinico A. Gemelli IRCCS, Presidio Columbus, Rome, Italy

P257: Monitoring of calprotectin levels in IBD patients with point-of-care test CalproSmart™

ECCO '19 Copenhagen

Year: 2019
Authors:

L. Ulanova*1, E. Moerk1

1Calpro AS, Lysaker, Norway

P258: Abdominal pain and its relationship with clinical outcomes, biomarker levels, and health-related quality of life in patients with moderate to severe ulcerative colitis: data from U-ACHIEVE, a Phase 2b study of upadacitinib

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Danese*1, E. Louis2, E. V. Loftus Jr3, F. Cataldi4, H. Guay4, W-J. Lee4, S. Ghosh5

1Istituto Clinico Humanitas, Department of Gastroenterology, Milan, Italy, 2University Hospital CHU of Liège, Liège, Belgium, 3Mayo Clinic College of Medicine, Rochester, USA, 4AbbVie Inc., North Chicago, USA, 5University of Birmingham, Institute of Immunology and Immunotherapy, NIHR Biomedical Research Centre, Institute of Translational Medicine, Birmingham, UK

P259: Systematic assessment of patient self-reported signs, symptoms, and nutrition behaviour

ECCO '19 Copenhagen

Year: 2019
Authors:

V. Pittet*1, M. H. Maillard2, P. Michetti2, Swiss IBD Cohort Study1

1Institute of Social and Preventive Medicine, Healthcare Evaluation Unit, Lausanne, Switzerland, 2Crohn and Colitis Center, Gastroenterology Beaulieu SA, Lausanne, Switzerland

P260: Disease duration in Crohn’s disease is a strong determinant for having a colectomy in geriatric population

ECCO '19 Copenhagen

Year: 2019
Authors:

H. Htet*1, T. Mudege1, S. Hoque1

1Whipps Cross Hospital, Barts Health NHS Trust, London, UK

P261: Frequency of B-cell subsets in infliximab-treated paediatric IBD patients

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Schnell*1, B. Schwarz1, M. Wahlbuhl-Becker1, I. Allabauer1, T. Rechenauer1, G. Siebenlist1, S. Kaspar1, C. Ehrsam1, A. Rückel1, W. Rascher1, A. Hörning1

1Universitätsklinikum Erlangen, Kinder- und Jugendklinik, Erlangen, Germany

P262: Systematic review of development and content validity of patient-reported outcome measures in inflammatory bowel disease: do we measure what we measure?

ECCO '19 Copenhagen

Year: 2019
Authors:

E. van Andel*1, B. Koopmann1, D. van Asseldonk1, N. de Boer2, L. Mokkink3, C. Noomen1

1Northwest Clinics, Department of Gastroenterology and Hepatology, Alkmaar, The Netherlands, 2Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology and Metabolism Research Institute, Amsterdam, The Netherlands, 3Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Epidemiology and Biostatistics, EMGO Institute for Health and Care Research, Amsterdam, The Netherlands

P263: Association between inflammatory bowel diseases and the non-classical histocompatibility complex HLA-G

ECCO '19 Copenhagen

Year: 2019
Authors:

S. da Costa Ferreira1, I. Abiodoun Sadissou2, R. Serafim Parra3, M. Ribeiro Feitosa3, F. Santos Lizarte Neto4, D. Pretti da Cunha Tirapelli4, L. Naira Zambelli Ramalho5, O. Féres3, E. Antônio Donadi2, L. E. de Almeida Troncon1

1Division of Gastroenterology, Department of Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirao Preto, Brazil, 2Division of Clinical Immunology, Department of Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil, 3Division of Coloproctology, Department of Surgery and Anatomy, Ribeirão Preto Medical School, University of São Paulo, Ribeirao Preto, Brazil, 4Molecular Biology Laboratory, Department of Surgery and Anatomy, Ribeirão Preto Medical School, University of São Paulo, Ribeirao Preto, Brazil, 5Department of Pathology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil

P264: Assessing the risk for an intra-abdominal abscess in patients with Crohn's disease presenting to the emergency department

ECCO '19 Copenhagen

Year: 2019
Authors:

T. Khoury*1,2, S. Daher3, M. Massarwa3, W. Hazou3, D. Hackimian3, A. A. Benson3, E. Viener3, A. Mari2, W. Sbeit1, M. Mahamid2, E. Israeli3

1Galilee Medical Center, Institute of Gastroenterology and Liver Diseases, Naharia, Israel, 2The Nazareth Hospital, EMMS, Gastroenterology and Endoscopy United, Nazareth, Israel, 3Hadassah University Hospital, Ein Kerem, Institute of Gastroenterology and Liver Diseases, Jerusalem, Israel

P265: Pharmacokinetic and pharmacodynamic evaluation of radiological healing in Crohn’s disease patients treated with Infliximab: a TAILORIX MRE substudy

ECCO '19 Copenhagen

Year: 2019
Authors:

P. Bossuyt*1,2, E. Dreesen3, J. Rimola4, S. Devuysere5, Y. De Bruecker5, R. Vanslembrouck6, V. Laurent7, M. Zappa8, C. Savoye-Collet9, A. Gils3, S. Vermeire1, L. Peyrin-Biroulet10

1University Hospitals Leuven, Catholic University of Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium, 2Imelda General Hospital, Department of Gastroenterology, Bonheiden, Belgium, 3Catholic University of Leuven, Department of Pharmaceutical and Pharmacological Sciences, Leuven, Belgium, 4Hospital Clínic of Barcelona, IBD Unit, Radiology Department, Barcelona, Spain, 5Imelda General Hospital, Department of Radiology, Bonheiden, Belgium, 6University Hospitals Leuven, Catholic University of Leuven, Department of radiology, Leuven, Belgium, 7Nancy University Hospital, INSERM U947 and Department of Radiology, Vandoeuvre-lès-Nancy, France, 8Beaujon Hospital, Department of Radiology, Clichy, France, 9Rouen University Hospital, Normandy University, Department of Radiology, Rouen, France, 10Nancy University Hospital, INSERM U954 and Department of Hepato-Gastroenterology, Vandoeuvre-lès-Nancy, France

P266: Clinical significance of granulomas in Crohn’s disease: a meta-analysis

ECCO '19 Copenhagen

Year: 2019
Authors:

S. W. Hong1, H. Yoon*2, C. M. Shin2, Y. S. Park2, N. Kim1,2, D. H. Lee1,2, J. S. Kim1

1Seoul National University College of Medicine, Seoul, South Korea, 2Seoul National University Bundang Hospital, Seongnam-si, South Korea

P267: Relationship between morphological alteration of paneth cells and dysbiosis in patients with inflammatory bowel disease

ECCO '19 Copenhagen

Year: 2019
Authors:

K. Nagashima*1, K. Nakamura2, T. Katsurada1, Y. Shimizu2, Y. Yokoi2, S. Otagiri1, K. Yamanashi1, K. Kinoshita1, R. Onishi1, N. Sakamoto1, T. Ayabe2

1Hokkaido University Faculty of Medicine and Graduate School of Medicine, Division of Endoscopy/Department of Gastroenterology and Hepatology, Sapporo, Japan, 2Hokkaido University, Faculty of Advanced Life, Science Graduate School of Life Science, Department of Cell Biological Science, Sapporo, Japan

P268: Eosinophil-derived neurotoxin (eosinophil protein x) showed higher specificity and positive predictive value for detecting disease activity in inflammatory bowel disease compare to faecal calprotectin

ECCO '19 Copenhagen

Year: 2019
Authors:

I. Lyutakov*1, R. Nakov1, V. Nakov1, B. Vladimirov1, B. Asenova2, M. Chetirska2, A. Dimov3, R. Vatcheva-Dobrevska2, P. Penchev1

1University Hospital ‘Tsaritsa Yoanna – ISUL’, Gastroenterology Clinic, Sofia, Bulgaria, 2University Hospital ‘Tsaritsa Yoanna – ISUL’, Microbiology and Virology Department, Sofia, Bulgaria, 3University of National and World Economy, Department of Statistics and Econometrics, Sofia, Bulgaria

P269: Utility of capsule endoscopy in the diagnosis of inflammatory bowel disease and its disease extent

ECCO '19 Copenhagen

Year: 2019
Authors:

S. H. S. Bong*1, W. J. Lee2,3, M. M. Aw3,4, S. H. Quak3,4, E. J. Goh5, M. Gowans2,3, D. E. Ong2,3, J. L. Hartono2,3

1National University Health System, University Medicine Cluster, Singapore, Singapore, 2National University Health System, Division of Gastroenterology and Hepatology, Singapore, Singapore, 3National University of Singapore, Yong Loo Lin School of Medicine, Singapore, Singapore, 4National University Health System, Khoo Teck Puat-National University Children’s Medical Institute, Singapore, Singapore, 5University of Auckland, Auckland, New Zealand

P270: Clinical and radiologic characteristics of intra-abdominal fistulising Crohn's disease

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Benson*1, E. Aviran1, S. Yaari1, N. Lev Cohain1, J. Sosna1, R. Oren1, E. Israeli1

1Hadassah University Medical Center, Jerusalem, Israel

P271: Role of magnetic resonance in imaging of mesentery in Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Surowiecka-Pastewka*1,2, M. Frączek3,4, J. Walecki3,4, M. Durlik1,2

1CSK Mswia, Department of Gastroenterological Surgery and Transplantation, Warsaw, Poland, 2Mossakowski Medical Research Centre of the Polish Academy of Sciences, Department of Surgical Research and Transplantology, Warsaw, Poland, 3CSK MSWiA, Diagnostic Radiology Department, Warsaw, Poland, 4Medical Centre of Postgraduate Education, Warsaw, Poland

P272: Developing a novel medication adherence index to determine reasons for nonadherence in inflammatory bowel disease

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Zand*1, A. Nguyen1, Z. Stokes1, C. Reynolds1, M. Dimitrova1, J. Sauk1, D. Hommes1

1University of California, Los Angeles, Vatche and Tamar Manoukian Division of Digestive Diseases, Center for Inflammatory Bowel Diseases, Los Angeles, USA